| ²é¿´: 545 | »Ø¸´: 0 | ||
qxjktq602ͳæ (³õÈëÎÄ̳)
|
[ÇóÖú]
¹ØÓÚÕâ¶ÎÎÄ×ֵĽâÊÍ
|
|
¸ßÊÖ·ÒëÏÂÃæÒ»¶Î»°£¬ÊÇÎÄÏ×Öе쬷Òë³ÉÖÐÎÄ£¬Íò·Ö¸Ðл Disturbances in insulin and possibly insulin growth factor-1 (IGF-1) signaling in the brain, especially the hippocampus, have been observed in Alzheimer¡¯s disease. The deletion of insulin receptor and insulin receptor substrate (IRS)-2 in neurons delays brain growth and prevents memory dysfunction in mice by the ablation of the phosphoinositide-3-kinase/Akt/ mammalian target of rapamycin (mTOR) pathway in neurons . The activation of mTOR suppresses the autophagic process in neurons and high concentrations of potentially toxic ¦Â-amyloid and tau proteins are sustained in the neurons . However, by contrast, both IRS-1 and IRS-2 expressions decrease in neurons of humans with Alzheimer¡¯s disease and both insulin and IGF-1 signaling are patently disturbed in brains affected by Alzheimer¡¯s disease. Type 2 diabetic patients have increased levels of hyperphosphorylated tau in their brains that facilitate the formation of neurofibrillary tangles that induce cognitive dysfunction . Induction of experimental diabetes with streptozotocin or analogous drugs increases the levels of ¦Â-amyloid and tau phosphorylation in rodents. Thus, the proper maintenance of insulin receptor signaling in the hippocampus plays an important role in cognitive function. |
» ²ÂÄãϲ»¶
²ÄÁϹ¤³Ì085601£¬270Çóµ÷¼Á
ÒѾÓÐ24È˻ظ´
085404 293Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
µ÷¼Á
ÒѾÓÐ21È˻ظ´
¸´ÊÔµ÷¼Á£¬Ò»Ö¾Ô¸Ö£ÖÝ´óѧ²ÄÁÏÓ뻯¹¤289·Ö
ÒѾÓÐ15È˻ظ´
08¹¤¿ÆÇóµ÷¼Á290·Ö
ÒѾÓÐ12È˻ظ´
286Çóµ÷¼Á
ÒѾÓÐ16È˻ظ´
²ÄÁÏÀà284µ÷¼Á
ÒѾÓÐ24È˻ظ´
¿¼Ñе÷¼Á-²ÄÁÏÀà-284
ÒѾÓÐ14È˻ظ´
327Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
Ò»Ö¾Ô¸985³õÊÔ354·ÖÉúÎïµ÷¼Á
ÒѾÓÐ3È˻ظ´
ÕÒµ½Ò»Ð©Ïà¹ØµÄ¾«»ªÌû×Ó£¬Ï£ÍûÓÐÓÃŶ~
Ͷ¸åºó±à¼ËµÎÄÕÂÖеÄÒ»¶Î»°Óë֮ǰµÄһƪÎÄÕ¼¸ºõÒ»Ñù£¬ÒªÇó½âÊÍ£¬Ôõô°ì£¿
ÒѾÓÐ6È˻ظ´
Õâ¾ä»°ÊÇʲôÒâ˼£¿
ÒѾÓÐ18È˻ظ´
Çë½âÊÍÒ»ÏÂÕâ¶Î»°¡£¹ØÓÚÄÜ´ø¼ò²¢µÄ¡£Ð»Ð»
ÒѾÓÐ11È˻ظ´
´ó¼Ò°ïæ¿´¿´£¬SCIУ¸åʱ±à¼·¢¹ýÀ´µÄÕâ¶Î»°µÄÒâ˼
ÒѾÓÐ9È˻ظ´
Çë½ÌͶ¸åÒªÇóÀïÕâµÄÒ»¶Î»°ÊÇʲôÒâ˼£¬Ð»Ð»£¡
ÒѾÓÐ3È˻ظ´
figure legendµ½µ×Ö¸µÄÊÇʲôѽ
ÒѾÓÐ19È˻ظ´
Çë¸ßÈ˽â´ð£¬Õâ¶Î»°ÊÇʲôÒâ˼£¿°æÃæ·Ñ$3000£¿
ÒѾÓÐ7È˻ظ´
[¼±ÎÊ] ÊÕµ½proofÁË£¬Õâ¾ä»°Ê²Ã´Òâ˼
ÒѾÓÐ8È˻ظ´
TgÒÔÏ·Ö×ÓÁ´¶ÎÊDz»ÄÜÔ˶¯£¬Õâ¾ä»°ÊÇ´íµÄ£¬ËÄܽâÊÍÏÂ
ÒѾÓÐ34È˻ظ´
ÇóÖúÕâ¶Î»°Ö÷Òªº¬Òå
ÒѾÓÐ4È˻ظ´
Çë½ÌͶ¹ýJAPSµÄ³æ×Ó£¬Õâ¾ä»°Ê²Ã´Òâ˼°¡£¿
ÒѾÓÐ5È˻ظ´
¿´¿´±ðÈ˽öÓÃVASP×öDOS¼ÆËã·¢ºÃÎÄÕ£¨Á½ÆªPRL£©
ÒѾÓÐ30È˻ظ´
ÇóÖúÒ»¶Î»°µÄÒâ˼
ÒѾÓÐ3È˻ظ´
Ͷ¸åÒªÇóÀÓÐÕâôһ¶Î»°´ó¸ÅÊÇʲôÒâ˼£¿£¿£¿£¨¾³£·¢ÂÛÎĵİï°ï棩
ÒѾÓÐ6È˻ظ´
¿ÆÑдÓСľ³æ¿ªÊ¼£¬ÈËÈËΪÎÒ£¬ÎÒΪÈËÈË













»Ø¸´´ËÂ¥
µã»÷ÕâÀïËÑË÷¸ü¶àÏà¹Ø×ÊÔ´